— Know what they know.
Not Investment Advice
Also trades as: CSL.AX (ASX) · $vol 194M · CMXHF (OTC) · $vol 0M

CSLLY OTC

CSL Limited
1W: -2.0% 1M: -1.2% 3M: +42.0% YTD: +8.9% 1Y: -5.4% 3Y: -19.2% 5Y: -41.2%
$30.50
-0.44 (-1.42%)
 
Weekly Expected Move ±4.5%
$28 $29 $31 $32 $33
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 58 · $118.1B mcap · 3.87B float · 0.0092% daily turnover · Short 37% of daily vol

Cash Flow Trends

Operating Cash Flow
$3.5B -0.9% ▼
5Y CAGR: -0.5%
Capital Expenditures
$649M +36.2% ▲
5Y CAGR: -11.5%
Free Cash Flow
$2.9B +13.2% ▲
5Y CAGR: +3.5%
Dividends Paid
$1.4B +1.1% ▲
Buybacks
$727M +0.0% ▲
Net Change in Cash
-$644M -225.3% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2022FY2023FY2024FY2025FY2026
— Operating Activities —
Net Income$2.1B$2.2B$2.7B$0-$2.6B
Depreciation & Amort.$516M$823M$954M$0$1.0B
Stock-Based Comp.$117M$139M$0$0$0
Change in Working Capital-$797M-$625M-$1.6B-$878M-$617M
Other Non-Cash Items$2.4B$2.5B$709M$4.4B$5.7B
Operating Cash Flow$2.6B$2.6B$2.8B$3.6B$3.5B
— Investing Activities —
Capital Expenditures-$1.2B-$1.7B-$849M-$636M-$1.3B
Acquisitions (Net)-$388M-$10.5B$0$167M$5M
Investment Purchases-$388M$464M$0$0-$5M
Investment Sales$0$272M$0$0$9M
Other Investing-$700K-$353M-$410M-$381M-$3M
Investing Cash Flow-$1.6B-$11.8B-$1.3B-$850M-$1.3B
— Financing Activities —
Net Debt Issuance$3.8B$1.7B$41M-$735M-$472M
Stock Repurchased$0$0$0$0-$727M
Dividends Paid-$988M-$1.1B-$1.2B-$1.4B-$1.4B
Other Financing-$50M-$80M-$152M-$89M-$253M
Financing Cash Flow$7.7B$456M-$1.3B-$2.2B-$2.8B
Net Change in Cash$8.6B-$8.8B$134M$514M-$644M
Cash End of Period$10.3B$1.5B$1.6B$2.2B$1.5B
Free Cash Flow$1.4B$909M$1.5B$2.5B$2.9B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms